Come and join us to meet the leading experts of the field participating in the panel discussion and sessions!


Thursday 30.3.2023


08:45 – 9:30 Registration and coffee

9:30 – 9:40 Opening words


9:40 – 11:00 Session 1: Epidemiology  (8 min + 2 min for Q&A)

Eili Huhtamo: Sindbis and other mosquito borne viruses in Finland: past, present and future

Ushanandini Mohanraj: Significant association with high prevalence and activity of cutavirus in parapsoriasis skin

Jenni Virtanen: Epidemiology, characterization, and diagnostics of equine pastern dermatitis and parapoxvirus

Lorna Culverwell: Characterisation of the RNA Virome of Nine Ochlerotatus Species in Finland

Olli Vapalahti: Molecular epidemiology of introduction and spread of emerging viruses, Finland (13 min + 2 min for Q&A)


11:00 – 12.00 Session 2: Vaccines  (8 min + 2 min for Q&A)

Timo Vesikari: New 3-antigen hepatitis B vaccine: High immune response rate and good persistence of anti-HBs antibodies compared with conventional hepatitis B vaccine in adults (13 min + 2 min for Q&A)

Vesa Hytönen: Display of antigens on virus-like particles

Vili Lampinen: SpyCatcher-mediated influenza M2e peptide display is more immunogenic than direct genetic fusion on the norovirus-like particle

Miao Jiang: COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs

Arttu Reinholm: COVID-19 vaccinated health care workers show relatively high rate of breakthrough infections and reduced neutralizing antibody activity against multiple Omicron variants and subvariants


12:00 – 13:00 Lunch (restaurant)


13:00 – 14:00 Session 3: Vaccine development in Finland

Arto Palmu: Update of Finnish Vaccine Research FVR

Kalle Saksela: Update of Finnish coronavirus vaccine

Heikki Hyöty: Update of Research Center for Vaccine Development and Immunology VACCIM


14:00 – 15:00 Paneelikeskustelu “Mitä opimme koronaviruspandemiasta?”

 Carita Savolainen-Kopra, Mika Rämet, Ilkka Julkunen, Kalle Saksela, Olli Vapalahti


15:00 – Coffee (exhibition area)


15:20 – 16:15 Pitch talk session 1 (exhibition area) (3 min + 1 min for Q&A)

Milja Belik: T cell responses to SARS-CoV-2 variants in thrice COVID-19 mRNA vaccinated health care workers

Phuoc Truong Nguyen: Virus-host interactions and prediction of putative hosts in Flavivirus and Coronaviridae

Pinja Jalkanen: T cell responses following COVID-19 vaccination in primary immunodeficiency patients

Oona Liedes: Declined Omicron infection-induced hybrid immunity against Omicron subvariants BQ.1.1, XBB.1 and XBB.1.5

Leo Hannolainen: Reactivation of chromosomally integrated HHV-6 in a solid transplant recipient

Lari Pyöriä: Genomic landscape of human tissue-resident DNA virome

Sally Chesnut: Identifying acute human protoparvovirus infections

Tatiana Demina: Viral diversity in Antarctic sea ice

Ankita Gupta: Presence of Porcine Noroviruses in Finnish Pigs

Katja Lind: Performance of dried real-time PCR reagents for influenza A virus detection


16:15 – 17:00 Session 4: Diagnostics  (8 min + 2 min for Q&A)

Niko Tervo: Integration and perspectives of NGS in a public health laboratory

Maria Perdomo: Unmasking the eukaryotic DNA virome

Eeva Auvinen: HPV self-sampling in cervical cancer screening

Pekka Kolehmainen: Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers


17:00 – 18:30 Free-time


18:30 – 19:30 Pitch talk session 2 (exhibition area)  (3 min + 1 min for Q&A)

Ausra Domanska: Molecular Organisation of Tick-Borne Encephalitis Virus

Fanny Frejborg: Characteristics and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1

Jussi Palomäki: Attenuated replication competent HSV expressing Has2 gene of naked mole rat shows enhanced oncolytic effect in glioblastoma and colon carcinoma cells

Ashwini Kedari: Insight into rabies virus neutralization revealed by an engineered antibody scaffold

Sergei Gurianov: Crystal structure of Parechovirus A 3Dpol RNA-dependent RNA polymerase

Satu Hakanen: Prelytic nuclear egress of progeny parvovirus capsids

Rupesh Balaji Jayachandran: Structural analysis of sars-cov-2 neutralization by a spike-targeting patient-derived monoclonal antibody

Liina Hannula: Structural basis for SARS-CoV-2 neutralization by small inhibitor protein TriSb92

Vinaya Venkat: Understanding SARS-CoV-2 transmission, infection and susceptibility in Neovison vison

Larissa Laine: The cross-species role of coronavirus nucleocapsid protein in innate immune evasion and its effect on viral replication

Zlatka Plavec: Structural Studies Reveal that Endosomal Cations Promote Formation of Infectious Coxsackievirus A9 A-Particles, Facilitating RNA and VP4 Release

Maija Suvanto: Characterization of two orbiviruses isolated from Finnish Ochlerotatus communis mosquitoes

Marika Skön: A comparison of the IFN responses induced by seasonal and avian influenza viruses in human moDCs

Jutta Laiho: HEDIMED, Human Exposomic Determinants of Immune Mediated Diseases


19:30 – Dinner and other evening activities



Friday 31.3.2023


8:00 – 9:30 Session 5: Antivirals and treatments  (8 min + 2 min for Q&A)

Päivi Ojala: SOX18 transcription factor as an attractive molecular target for Kaposi’s sarcoma, a viral cancer

Kiira Kalke: Antiviral UL29-targeted siRNA swarms in treatment of HSV-1 infection

Dhanik Reshamwala: Polyphenols Epigallocatechin Gallate and Resveratrol, and Polyphenol-Functionalized Nanoparticles Prevent Enterovirus Infection through Clustering and Stabilization of the Viruses

Leonóra Szirovicza: Characterization and molecular biology of Daletvirus boae – a founding member of the realm Ribozyviria

Aditya Thiruvaiyaru: Host factors essential for efficient alphavirus replication

Sailee Shroff: Resin-functionalized plastic surface kills infectivity of Human Coronaviruses

Tania Quirin: The human nasal epithelium in vitro to study respiratory viral infections

Emil Loikkanen: Inactivation of hepatitis E -virus (HEV) and its surrogate virus murine norovirus (MNV) during industrial cold smoking process.


9:30 – 10:30 My life, my viruses – Senior virologists’ speeches

 Veijo Hukkanen, Klaus Hedman


10:30 – Coffee (exhibition area)


10:50 – 11.30 Pitch talk session 3 (exhibition area)  (3 min + 1 min for Q&A)

Petri Susi: Cell infectivity and genome profiles of echovirus 7 isolates and Rigvir® oncolytic virotherapy virus

Elina Väisänen: Infectious viruses from transfected SARS-CoV-2 genomic RNA

Kyrylo Bisikalo: Studying TBEV using BSL2 model – rLGTV

Sari Maljanen: Full Steam Ahead

Hanna Oksanen: State-of-the-art research services and resources by ISIDORe to study viruses and epidemic-prone pathogens

Visa Ruokolainen: Exploring nuclear details of herpesvirus infection using expansion microscopy


11:30 – 12:30 Session 6: Pathogenesis  (8 min + 2 min for Q&A)

Anni Honkimaa: JC polyomavirus modifies the expression of crucial human microRNAs in PML brain

Moona Huttunen: Vaccinia virus hijacks ESCRT-mediated multivesicular body formation for virus egress

Salla Mattola: Parvovirus infection alters the nucleolar organization

Ravi Ojha: Multiple endocytic mechanisms mediate SARS-CoV-2 cell entry and infection

Maria Anastasina: Tick-Borne Encephalitis Virus Maturation


12:30 – 13:15 Lunch (exhibition area)


13:15 – 15:00 Session 7: Virus and host  (8 min + 2 min for Q&A)

Ilkka Julkunen: Mammalian Filovirus VP24 matrix proteins downregulate innate immune response by inhibiting the interferon induced pathway (13 min + 2 min for Q&A)

Annika Lintala: Reptarenavirus Co- and Superinfection in Cell Culture Sheds Light on the S and L Segment Accumulation in Captive Snakes

Rommel Iheozor-Ejiofor: Neutralizing Antibody Titers in Hospitalized Patients with Acute Puumala Orthohantavirus Infection Do Not Associate with Disease Severity

Vesa Aho: HSV-1 capsid motion reveals infection-induced changes in the intranuclear environment

Mert Erdin: Strain-specific in silico analysis of Dobrava-Belgrade orthohantavirus Gn ectodomain DAF/CD55 interaction

Simon Leclerc: Herpesvirus-induced changes in the structure and function of mitochondria

Sini Huuskonen: Characterizing the viral-host interaction changes of SARS-CoV-2 variants via BioID-MS

Pamela Österlund: Antiviral evasion strategies of avian influenza viruses


15:00 – 15:10 Closing remarks